BOSTON, Oct. 16, 2015 /PRNewswire/ -- Invuity, Inc.
(NASDAQ:IVTY), an advanced medical technology company, today at the
84th American Society of Plastic Surgeons annual
scientific conference, Plastic Surgery: The Meeting, announced the
introduction of Eikon™ LT with Tissue Grip to its illuminated
retractor platform. Invuity's latest innovation expands clinical
applicability and enables broader adoption in the plastic surgery
market.
Expanding on the company's Eikon LT platform of non-conductive
illuminated retractor systems, Eikon LT with Tissue Grip features
atraumatic teeth on the distal tip of the retractor blade. This
feature provides plastic surgeons the additional grip needed to
create the desired breast pocket underneath the pectoral muscle for
placement of a tissue expander or implant during surgery, while
minimizing tissue trauma. All Eikon LT devices integrate Invuity's
Intelligent Photonics™ technology to offer superior intra-cavity
illumination and visualization.
Eikon LT with Tissue Grip addresses key safety priorities for
hospitals and health systems. The non-conductive material
eliminates the risk of potential burns due to arcing from
electrosurgical devices, thus improving patient safety. This
material, coupled with Invuity's proprietary thermally cool
illumination, virtually eliminates the known thermal hazards
associated with traditional electrosurgical devices and fiber
optics. Furthermore, all devices in the platform feature a
lightweight, ergonomic design that reduces surgeon fatigue and
provides surgical precision.
"With more women undergoing immediate breast reconstruction
after breast cancer surgery, now more than ever, we need surgical
technologies that enable us to operate with greater precision and
safety," said C. Andrew Salzberg,
MD, Associate Professor of Plastic Surgery, and the Director of
Integrated Plastic Surgery Services at the Mount Sinai Health
System in New York City and the
Chief of Plastic Surgery at St. John's Riverside Hospital at
Dobbs Ferry in Westchester. "Eikon LT with Tissue Grip allows
me to operate more efficiently and give patients the cosmetic
results they desire without the risk of thermal injury."
For more information, please visit booth #232 at Plastic
Surgery: The Meeting 2015 or
http://invuity.com/products/retractors/eikon-lt.
About Invuity®
Invuity, Inc. is a medical
technology company focused on developing and marketing advanced
photonics devices to improve the ability of surgeons to illuminate
and visualize the surgical cavity during minimally invasive and
minimal access open surgery. The company's patented Intelligent
Photonics™ technology enables enhanced surgical precision,
efficiency and safety by providing superior visualization. Clinical
applications include breast and thyroid oncology, plastic
reconstructive, spine, orthopedic, cardiothoracic and general
surgery among others. Invuity is headquartered
in San Francisco, CA. For more information, visit
www.invuity.com.
Forward-Looking Statements
This announcement contains
forward-looking statements that involve risks and uncertainties,
including statements regarding market opportunities and potential
results from future new initiatives. Actual results could differ
materially from those projected in the forward-looking statements
as a result of certain risk factors, including, but not limited to:
fluctuations in demand or failure to gain market acceptance for the
Company's devices; the Company's ability to demonstrate to and gain
approval from hospitals to use the Company's devices; the highly
competitive business environment for surgical medical devices; the
Company's ability to sell its devices at prices that support its
current business strategies; difficulty forecasting future
financial performance; protection of the Company's intellectual
property; and compliance with necessary regulatory clearances or
approvals. The Company undertakes no obligation to update the
forward-looking information in this release. More information about
potential factors that could affect the Company's business and
financial results is included in its filings with the Securities
and Exchange Commission, including, without limitation, under the
captions: "Management's Discussion and Analysis of Financial
Condition and Results of Operations," and "Risk Factors," which are
on file with the Securities and Exchange Commission.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/invuity-announces-eikon-lt-illuminated-retractor-with-tissue-grip-for-plastic-surgery-300160794.html
SOURCE Invuity, Inc.